CLOSE [X]
The Ramirez Laboratory employs molecular genetic strategies to identify novel therapeutic targets and/or prognostic markers in aortic aneurysm, osteoporosis and fibrotic conditions. Read More
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting May 17, 2012 - Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Mount Sinai Prostate Cancer Surgeon Performs 4000th Robotic-Assisted Radical Prostatectomy May 15, 2012 - David Samadi, MD, Vice Chairman of Urology, achieved the milestone this spring.
Protein Inhibitor Points To Potential Medical Treatments For Skull And Skin Birth Defects May 15, 2012 - Mount Sinai researchers have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder.
Francesco Ramirez, DSc Principal Investigator Tel: 212-241-7237 Fax: 212-996-7214 Send e-mail
Karen J. Johnson Administrative Coordinator Tel: 212-241-7245 Fax: 212-996-7214 Send e-mail
Pharmacology and Systems Therapeutics 1468 Madison Avenue New York, NY 10029
